ArticleACS omega2025
Integrated Blood Multiparameter Precise Sensing System for Economical, Rapid, and Accurate Detection of Blood Biochemical Indicators: From Centrifugation to Sensing.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Blood is enriched with physiological information and could provide valuable references for the diagnosis of various diseases. Influenced by a few factors, including glycolysis, the direct testing of blood may lead to biased results. Healthcare facilities routinely eliminate this bias by centrifugation. However, conventional centrifuges and analysis equipment are large and electricity dependent, limiting their application in less-developed regions. In this work, an integrated blood multiparameter precise sensing system (BMPSS), consisting of a portable manual centrifuge (PMC) and three flex sensor patches (FSPs), was developed for rapid manual centrifugation of blood and detection of glucose, cholesterol, and uric acid levels in postcentrifugation plasma. The test results in solution illustrated that FSPs have favorable linear responsiveness, reproducibility, temporal stability, and selectivity. Experimental results based on rat blood indicated that the PMC has centrifugation results similar to those of commercial centrifuges, and the BMPSS enables adequate centrifugation and precise detection of blood, leading to indications of a wide range of diseases. The results conclusively point to the potential clinical applicability of BMPSS. This work presents the first system that achieves low-cost, portable, electricity-free centrifugation and in situ rapid sample testing; we believe it has promising applications in harsh environments.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.